Evidence map›Paper›PMID 31809566›Full record

Observational studyCancer2020

Patient-hematologist discordance in perceived chance of cure in hematologic malignancies: A multicenter study.

Kah Poh Loh, Huiwen Xu, Anthony Back, Paul R Duberstein, Supriya Gupta Mohile, Ronald Epstein, Colin McHugh, Heidi D Klepin, Gregory Abel, Stephanie J Lee and 2 more

Abstract readMulticenter StudyObservational Study
In one paragraph

Observational study in Cancer, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Challenges in hospice and end-of-life care in the transfusion-dependent patient.Hematology. American Society of Hematology. Education Program · 2024
    Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Behavioral Patterns in Breaking Bad News Communication: An Ethnographic Study with Hematologists.International journal of environmental research and public health · 2022
    Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Kah Poh LohJames P. Wilmot Cancer Center, University of Rochester Medical Center, Rochester, New York.ORCID 0000-0002-6978-0418
Huiwen XuDepartment of Surgery, Cancer Control, University of Rochester School of Medicine and Dentistry, Rochester, New York.ORCID 0000-0002-4033-0659
Anthony BackClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
Paul R DubersteinDepartment of Health Behavior, Society, and Policy, Rutgers School of Public Health, Piscataway, New Jersey.ORCID 0000-0001-6882-0898
Supriya Gupta MohileJames P. Wilmot Cancer Center, University of Rochester Medical Center, Rochester, New York.ORCID 0000-0003-0867-327X
Ronald EpsteinJames P. Wilmot Cancer Center, University of Rochester Medical Center, Rochester, New York.
Colin McHughJames P. Wilmot Cancer Center, University of Rochester Medical Center, Rochester, New York.
Heidi D KlepinSection on Hematology and Oncology, Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, North Carolina.ORCID 0000-0002-6262-1123
Gregory AbelDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
Stephanie J LeeClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
Areej El-JawahriDepartment of Hematology-Oncology, Massachusetts General Hospital Cancer Center, Boston, Massachusetts.ORCID 0000-0002-3556-1495
Thomas W LeBlancDivision of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University School of Medicine, Durham, North Carolina.ORCID 0000-0002-0546-7895

Funding

URCC NCORP Research BaseUG1CA189961 · NCI · UNIVERSITY OF ROCHESTER · PI Michelle C Janelsins, KAREN M. MUSTIAN · 2014 to 2026
$67.7M
Enhancing Doctor-Patient CommunicationR01CA098486 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI LEE, STEPHANIE J · 2003 to 2006
$1.9M
A novel mobile health exercise intervention for older patients with myeloid neoplasmsR00CA237744 · NCI · UNIVERSITY OF ROCHESTER · PI LOH, KAH POH · 2021 to 2023
$747k
A Novel Mobile Health Exercise Intervention for Older Patients with Myeloid NeoplasmsK99CA237744 · NCI · UNIVERSITY OF ROCHESTER · PI LOH, KAH POH · 2019 to 2020
$385k
NCI NIH HHS K99 CA237744NCI NIH HHS R00 CA237744NCI NIH HHS R01 CA098486NCI NIH HHS UG1 CA189961
6 · The paper itself

Abstract

backgroundEnsuring that patients with hematologic malignancies have an accurate understanding of their likelihood of cure is important for informed decision making. In a multicenter, longitudinal study, the authors examined discordance in patients' perception of their chance of cure versus that of their hematologists, whether patient-hematologist discordance changed after a consultation with a hematologist, and factors associated with persistent discordance.

methodsBefore and after consultation with a hematologist, patients were asked about their perceived chance of cure (options were <10%, 10%-19%, and up to 90%-100% in 10% increments, and "do not wish to answer"). Hematologists were asked the same question after consultation. Discordance was defined as a difference in response by 2 levels. The McNemar test was used to compare changes in patient-hematologist prognostic discordance from before to after consultation. A generalized linear mixed model was used to examine associations between factors and postconsultation discordance, adjusting for clustering at the hematologist level.

resultsA total of 209 patients and 46 hematologists from 4 sites were included in the current study. Before consultation, approximately 61% of dyads were discordant, which improved to 50% after consultation (P < .01). On multivariate analysis, lower educational level (<college vs postgraduate: odds ratio [OR], 2.24; 95% CI, 1.02-4.92), higher social support-affection subscale score (1-unit change in score: OR, 1.15; 95% CI, 1.00-1.32), and discordance before consultation (OR, 6.17; 95% CI, 2.99-12.72) were found to be significantly associated with discordance after consultation.

conclusionsPatient-hematologist concordance in prognostic understanding appears to improve after a hematology consultation, but approximately one-half of patients' views of their prognoses were found to remain discordant with those of their hematologists. Interventions are needed to improve prognostic understanding among patients with hematologic malignancies.

Indexed as

ConsensusAdaptation, PsychologicalClinical Decision-MakingDenial, PsychologicalEducational StatusFemaleHematologic NeoplasmsHematologyHumansLongitudinal StudiesMaleMiddle AgedMultivariate AnalysisOdds RatioQuality of LifeSocial Supportdiscordancehematologic malignanciesperceived chance of cureprognostic understanding

Identifiers

PMID31809566
PMCPMC7050385

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.